SCHEMBL31424

SCHEMBL31424

CNS(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL29038378 0.95
SCHEMBL2557723 0.95
Hydrochloric Acid SCHEMBL30776679 0.95
Bromide SCHEMBL29059452 0.95
Hydrochloric Acid SCHEMBL6441129 0.95
SCHEMBL11027096 0.95
Cyclopropane SCHEMBL16235826 0.88
Dimethyl Sulfoxide SCHEMBL14935714 0.82 CA2 (0.37)
Formic Acid SCHEMBL15917099 0.82
Ether SCHEMBL29184007 0.77 CA2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8231 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4294800-B1 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS INC (US) 2026-05-06 EP claimed
EP-4658661-A1 MACROCYCLIC AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS Yuhan Corporation (KR) 2025-12-10 EP claimed
US-20250248979-A1 NOVEL GPX4 INHIBITORS AND USES THEREOF UNIV COLUMBIA (US) 2025-08-07 US claimed
EP-4593822-A2 NOVEL GPX4 INHIBITORS AND USES THEREOF The Trustees Of Columbia University In The City Of New York (US) 2025-08-06 EP claimed
EP-4573089-A2 KRAS INHIBITORS Bristol-Myers Squibb Company (US) 2025-06-25 EP claimed
CN-120202200-A Oxo-isoindolinyl substituted tetrahydropyrimidinedione-based compounds and applications thereof 标新生物医药科技(上海)有限公司 2025-06-24 CN claimed
CN-119998275-A KRAS inhibitors 百时美施贵宝公司 2025-05-13 CN claimed
US-20250136579-A1 SALTS AND FREE BASES OF BIFUNCTIONAL COMPOUND AND POLYMORPH FORMS THEREOF NURIX THERAPEUTICS, INC. 2025-05-01 US claimed
WO-2025090535-A2 SALTS AND FREE BASES OF BIFUNCTIONAL COMPOUND AND POLYMORPH FORMS THEREOF NURIX THERAPEUTICS, INC. (US) 2025-05-01 WO claimed
CN-119899122-A Cyclobutylmethyl and phenyl substituted curcumin derivative and preparation method and application thereof 常州大学 2025-04-29 CN claimed
EP-0071370-A2 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them ICI PHARMA (FR) 1983-02-09 EP claimed
EP-0055562-A2 Cephalosporin derivatives ICI PHARMA (FR) 1982-07-07 EP claimed
EP-0055099-A1 Penicillin derivatives ICI PHARMA (FR) 1982-06-30 EP claimed
US-4268509-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-05-19 US claimed
EP-0024906-A1 Miticidal, insecticidal, ovicidal and fungicidal diarylaminothio derivatives, and preparation, compositions and use thereof E.I. DU PONT DE NEMOURS AND COMPANY (US) 1981-03-11 EP claimed
EP-0007470-A2 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-02-06 EP claimed
US-4170547-A SOLVENT EXTRACTION COMPAGNIE FRANCAISE DE RAFFINAGE (FR) 1979-10-09 US claimed
US-4120960-A DIURETICS, SALURESIS THE BOOTS COMPANY LIMITED (GB) 1978-10-17 US claimed
US-4103009-A ANTIULCER AGENTS, DIURETICS NIPPON SHINYAKU CO., LTD. (JP) 1978-07-25 US claimed
US-4074028-A Dendrite-inhibiting electrolytic solution and rechargeable aqueous zinc-halogen cell containing the solution GENERAL ELECTRIC COMPANY (US) 1978-02-14 US claimed